PUBLICATIONS · 27402335
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Hematol Oncol
- Publication date
- 2017 Dec
- First author
- Pro B
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Pro B
- type
- Author
- name
- Horwitz SM
- type
- Author
- name
- Prince HM
- type
- Author
- name
- Foss FM
- type
- Author
- name
- Sokol L
- type
- Author
- name
- Greenwood M
- type
- Author
- name
- Caballero D
- type
- Author
- name
- Morschhauser F
- type
- Author
- name
- Wilhelm M
- type
- Author
- name
- Iyer SP
- type
- Author
- name
- Shustov AR
- type
- Author
- name
- Wolfson J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Pro B
- type
- Author
- name
- Horwitz SM
- type
- Author
- name
- Prince HM
- type
- Author
- name
- Foss FM
- type
- Author
- name
- Sokol L
- type
- Author
- name
- Greenwood M
- type
- Author
- name
- Caballero D
- type
- Author
- name
- Morschhauser F
- type
- Author
- name
- Wilhelm M
- type
- Author
- name
- Iyer SP
- type
- Author
- name
- Shustov AR
- type
- Author
- name
- Wolfson J
- type
- Author
- bibliography ids
- nci-bib-090504a0c291dc6d3f3315f9
- book metadata
- content sha256
- 2939dd6fa7b1faf14d727e078c4ef6c12f53b59b2cf925de73f0c99d50ec36f2
- document type
- citation
- dois
- 10.1002/hon.2320
- electronic publication date
- display
- 2016 Jul 12
- precision
- day
- year
- 2016
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:27402335
- immutable id
- pubmed:27402335@2939dd6fa7b1faf14d727e078c4ef6c12f53b59b2cf925de73f0c99d50ec36f2
- journal
- abbreviation
- Hematol Oncol
- issn electronic
- 1099-1069
- issn print
- 0278-0232
- issue
- 4
- name
- Hematological oncology
- nlm unique id
- 8307268
- pages
- 914-917
- volume
- 35
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 27402335
- provenance
- batch id
- d649bcb2d98dbbacd53c
- provider
- NCBI PubMed ESummary
- record sha256
- c768689829db1c11ed696d0a4c9f005526559a999be4aa9b070ab555cfabfa03
- response sha256
- 26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
- retrieved at
- 2026-09-09T23:47:20.761544+00:00
- publication date
- display
- 2017 Dec
- precision
- month
- year
- 2017
- publication types
- Clinical Trial
- Letter
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle